Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients

Intensive Care Medicine

Volumn 32, Issue 10, 2006, Pages 1577-1583

  Charles, Pierre Emmanuel ^a   Dalle, Frédéric ^a   Aho, Serge ^a   Quenot, Jean Pierre ^a   Doise, Jean Marc ^a   Aube, Hervé ^a   Olsson, Nils Olivier ^a   Blettery, Bernard ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; CALCULATION; CANDIDEMIA; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; MEDICAL RECORD; RECEIVER OPERATING CHARACTERISTIC; SEPSIS;

AGED; BACTEREMIA; C-REACTIVE PROTEIN; CALCITONIN; CANDIDIASIS; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; ROC CURVE;

EID: 33749242466     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0306-3     Document Type: Article

References (29)

1. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM (2005) Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 26:540-547
2. Charles PE, Doise JM, Quenot JP, Aube H, Dalle F, Chavanet P, Milesi N, Aho LS, Portier H, Blettery B (2003) Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29:2162-2169
3. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, Martinez-Gonzalez J, Leon-Regidor MA, Ibanez-Lucia P, Torres-Rodriguez JM (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infection in the ICU. Intensive Care Med 23:23-30
4. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B (2005) Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 31:393-400
5. Charles PE (2006) Multifocal candida species colonization as a trigger for early antifungal therapy in critically ill patients: what about other risk factors for fungal infection? Crit Care Med 34:913-914
6. Wahyuningsih R, Freisleben HJ, Sonntag HG, Schnitzler P (2000) Simple and rapid detection of candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis. J Clin Microbiol 38:3016-3021
7. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498-504
8. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396-402
9. Huber W, Schweigart U, Bottermann P (1997) Failure of PCT to indicate severe fungal infection in two immunodeficient patients. Infection 25:377-378
10. Christofilopoulou S, Charvalos E, Petrikkos G (2002) Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 13:493-495
11. Dornbusch HJ, Strenger V, Kerbl R, Lackner H, Schwinger W, Sovinz P, Urban C (2005) Procalcitonin - a marker of invasive fungal infection? Support Care Cancer 13:343-346
12. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, Mitterer M (2001) Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 115:53-57
13. Williams RL (2000) A note on robust variance estimation for cluster-correlated data. Biometrics 56:645-646
14. Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977-983
15. Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, May T, Hoen B (2002) Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 35:156-161
16. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, Schmidt-Wolf IG, Marklein G, Schroeder S, Stuber F (2004) Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than c-reactive protein. Eur J Clin Microbiol Infect Dis 23:539-544
17. Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, Cohen Y (2004) Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32:1166-1169
18. Pugin J (2002) Biomarkers of sepsis: is procalcitonin ready for prime time? Intensive Care Med 28:1203-1204
19. Christ-Crain M, Muller B (2005) Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med Wkly 135:451-460
20. Distefano G, Curreri R, Betta P, Romeo MG, Amato M (2004) Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants. Acta Paediatr 93:216-219
21. Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL (2005) Value of measuring serum procalcitonin, c-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur J Clin Microbiol Infect Dis 24:272-275
22. Eloy O, Vauloup C, Therond P, Pina P, Allouch P, Pangon B, Bedos JP, Ghnassia JC (2001) Procalcitonin level in deep-seated Candida infections. Ann Biol Clin (Paris) 59:502-505
23. Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H (2002) Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 28:1351-1356
24. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28:458-461
25. Tavares E, Maldonado R, Ojeda ML, Minano FJ (2005) Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats. Clin Diagn Lab Immunol 12:1085-1093
26. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B (2004) Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32:1715-1721
27. Astiz M, Saha D, Lustbader D, Lin R, Rackow E (1996) Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 128:594-600
28. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680-684
29. Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y (2006) Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 34:102-107